297 related articles for article (PubMed ID: 22232535)
1. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
Rosario DJ; Lane JA; Metcalfe C; Donovan JL; Doble A; Goodwin L; Davis M; Catto JW; Avery K; Neal DE; Hamdy FC
BMJ; 2012 Jan; 344():d7894. PubMed ID: 22232535
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
[TBL] [Abstract][Full Text] [Related]
3. Transrectal ultrasound guided biopsy for detecting early prostate cancer: An Indian experience.
Gupta NP; Ansari MS; Dass SC
Indian J Cancer; 2005; 42(3):151-4. PubMed ID: 16276016
[TBL] [Abstract][Full Text] [Related]
4. Repeat prostate-specific antigen (PSA) test before prostate biopsy: a 20% decrease in PSA values is associated with a reduced risk of cancer and particularly of high-grade cancer.
De Nunzio C; Lombardo R; Nacchia A; Tema G; Tubaro A
BJU Int; 2018 Jul; 122(1):83-88. PubMed ID: 29533522
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study.
Young GJ; Harrison S; Turner EL; Walsh EI; Oliver SE; Ben-Shlomo Y; Evans S; Lane JA; Neal DE; Hamdy FC; Donovan JL; Martin RM; Metcalfe C
BMJ Open; 2017 Oct; 7(10):e017729. PubMed ID: 29084797
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of transrectal ultrasound-guided prostate biopsy in men younger than 50 years old with an elevated prostate-specific antigen concentration (>4.0 ng/mL).
Lu CH; Lin TP; Shen SH; Huang YH; Chung HJ; Kuo JY; Huang WJS; Wu HHH; Chang YH; Lin ATL; Chen KK
J Chin Med Assoc; 2017 Jul; 80(7):413-418. PubMed ID: 28529023
[TBL] [Abstract][Full Text] [Related]
7. Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study.
Mkinen T; Auvinen A; Hakama M; Stenman UH; Tammela TL
Urology; 2002 Nov; 60(5):846-50. PubMed ID: 12429313
[TBL] [Abstract][Full Text] [Related]
8. The implication of initial 24-core transrectal prostate biopsy protocol on the detection of significant prostate cancer and high grade prostatic intraepithelial neoplasia.
Nomikos M; Karyotis I; Phillipou P; Constadinides C; Delakas D
Int Braz J Urol; 2011; 37(1):87-93; discussion 93. PubMed ID: 21385484
[TBL] [Abstract][Full Text] [Related]
9. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
[TBL] [Abstract][Full Text] [Related]
10. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
11. Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial.
Wade J; Rosario DJ; Howson J; Avery KN; Salter CE; Goodwin ML; Blazeby JM; Lane JA; Metcalfe C; Neal DE; Hamdy FC; Donovan JL
BMC Health Serv Res; 2015 Feb; 15():80. PubMed ID: 25889315
[TBL] [Abstract][Full Text] [Related]
12. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
[TBL] [Abstract][Full Text] [Related]
13. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
[TBL] [Abstract][Full Text] [Related]
14. Local anaesthetic transperineal (LATP) prostate biopsy using a probe-mounted transperineal access system: a multicentre prospective outcome analysis.
Lopez JF; Campbell A; Omer A; Stroman L; Bondad J; Austin T; Reeves T; Phelan C; Leiblich A; Philippou Y; Lovegrove CE; Ranasinha N; Bryant RJ; Leslie T; Hamdy FC; Brewster S; Bell CR; Popert R; Hodgson D; Elsaghir M; Eddy B; Bolomytis S; Persad R; Reddy UD; Foley C; van Rij S; Lam W; Lamb AD
BJU Int; 2021 Sep; 128(3):311-318. PubMed ID: 33448607
[TBL] [Abstract][Full Text] [Related]
15. Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures.
Wadhwa K; Carmona-Echeveria L; Kuru T; Gaziev G; Serrao E; Parashar D; Frey J; Dimov I; Seidenader J; Acher P; Muir G; Doble A; Gnanapragasam V; Hadaschik B; Kastner C
Asian J Androl; 2017; 19(1):62-66. PubMed ID: 26924279
[TBL] [Abstract][Full Text] [Related]
16. The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial.
Frånlund M; Carlsson S; Stranne J; Aus G; Hugosson J
BJU Int; 2012 Sep; 110(5):638-43. PubMed ID: 22540895
[TBL] [Abstract][Full Text] [Related]
17. A prospective study analysing the effect of pain on probe insertion, and the biopsy strategy, on the patients' perception of pain during TRUS-guided biopsy of the prostate.
Chopra S; Rowe EW; Laniado M; Patel A
N Z Med J; 2008 Dec; 121(1287):39-43. PubMed ID: 19098966
[TBL] [Abstract][Full Text] [Related]
18. Is it effective to perform two more prostate biopsies according to prostate-specific antigen level and prostate volume in detecting prostate cancer? Prospective study of 10-core and 12-core prostate biopsy.
Yoon BI; Shin TS; Cho HJ; Hong SH; Lee JY; Hwang TK; Kim SW
Urol J; 2012; 9(2):491-7. PubMed ID: 22641493
[TBL] [Abstract][Full Text] [Related]
19. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
[TBL] [Abstract][Full Text] [Related]
20. Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study.
Djavan B; Fong YK; Ravery V; Remzi M; Horninger W; Susani M; Kreuzer S; Boccon-Gibod L; Bartsch G; Marberger M
Eur Urol; 2005 Jan; 47(1):38-44; discussion 44. PubMed ID: 15582247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
